ABCL
Price
$2.69
Change
-$0.10 (-3.58%)
Updated
Dec 18, 04:59 PM (EDT)
69 days until earnings call
PSTX
Price
$9.42
Change
-$0.08 (-0.84%)
Updated
Dec 18, 04:28 PM (EDT)
78 days until earnings call
Ad is loading...

ABCL vs PSTX

Header iconABCL vs PSTX Comparison
Open Charts ABCL vs PSTXBanner chart's image
AbCellera Biologics
Price$2.69
Change-$0.10 (-3.58%)
Volume$106.46K
CapitalizationN/A
Poseida Therapeutics
Price$9.42
Change-$0.08 (-0.84%)
Volume$620
CapitalizationN/A
ABCL vs PSTX Comparison Chart
Loading...
ABCL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PSTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ABCL vs. PSTX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABCL is a Hold and PSTX is a Buy.

COMPARISON
Comparison
Dec 19, 2024
Stock price -- (ABCL: $2.79 vs. PSTX: $9.50)
Brand notoriety: ABCL and PSTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABCL: 87% vs. PSTX: 52%
Market capitalization -- ABCL: $844.75M vs. PSTX: $925.93M
ABCL [@Biotechnology] is valued at $844.75M. PSTX’s [@Biotechnology] market capitalization is $925.93M. The market cap for tickers in the [@Biotechnology] industry ranges from $486.73B to $0. The average market capitalization across the [@Biotechnology] industry is $2.67B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABCL’s FA Score shows that 0 FA rating(s) are green whilePSTX’s FA Score has 0 green FA rating(s).

  • ABCL’s FA Score: 0 green, 5 red.
  • PSTX’s FA Score: 0 green, 5 red.
According to our system of comparison, ABCL is a better buy in the long-term than PSTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABCL’s TA Score shows that 3 TA indicator(s) are bullish while PSTX’s TA Score has 6 bullish TA indicator(s).

  • ABCL’s TA Score: 3 bullish, 5 bearish.
  • PSTX’s TA Score: 6 bullish, 5 bearish.
According to our system of comparison, PSTX is a better buy in the short-term than ABCL.

Price Growth

ABCL (@Biotechnology) experienced а -7.62% price change this week, while PSTX (@Biotechnology) price change was +0.53% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -6.67%. For the same industry, the average monthly price growth was -1.92%, and the average quarterly price growth was +0.65%.

Reported Earning Dates

ABCL is expected to report earnings on Feb 25, 2025.

PSTX is expected to report earnings on Mar 06, 2025.

Industries' Descriptions

@Biotechnology (-6.67% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PSTX($926M) has a higher market cap than ABCL($796M). PSTX YTD gains are higher at: 182.738 vs. ABCL (-51.138). PSTX has higher annual earnings (EBITDA): -46.16M vs. ABCL (-202.4M). ABCL has more cash in the bank: 643M vs. PSTX (231M). ABCL has less debt than PSTX: ABCL (71.4M) vs PSTX (82.7M). PSTX has higher revenues than ABCL: PSTX (151M) vs ABCL (33M).
ABCLPSTXABCL / PSTX
Capitalization796M926M86%
EBITDA-202.4M-46.16M438%
Gain YTD-51.138182.738-28%
P/E RatioN/AN/A-
Revenue33M151M22%
Total Cash643M231M278%
Total Debt71.4M82.7M86%
TECHNICAL ANALYSIS
Technical Analysis
ABCLPSTX
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
76%
Bearish Trend 2 days ago
89%
Momentum
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
84%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
77%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
87%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
73%
Bullish Trend 2 days ago
85%
Advances
ODDS (%)
Bullish Trend 17 days ago
76%
Bullish Trend 8 days ago
87%
Declines
ODDS (%)
Bearish Trend 14 days ago
86%
Bearish Trend 20 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 7 days ago
90%
Bearish Trend 2 days ago
87%
Aroon
ODDS (%)
Bullish Trend 2 days ago
70%
Bullish Trend 2 days ago
78%
View a ticker or compare two or three
Ad is loading...
ABCL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PSTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JIISX80.53-0.25
-0.31%
JPMorgan US Sustainable Leaders I
PXWEX35.67-0.14
-0.39%
Impax Ellevate Global Women's Ldr Inv
HDPBX24.31-0.17
-0.69%
Hodges Blue Chip Equity Income Retail
OSGIX41.24-0.38
-0.91%
JPMorgan Mid Cap Growth A
AVUDX7.82-0.71
-8.34%
American Century Value R6

ABCL and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABCL has been loosely correlated with VCYT. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if ABCL jumps, then VCYT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABCL
1D Price
Change %
ABCL100%
-2.45%
VCYT - ABCL
56%
Loosely correlated
-2.52%
DNA - ABCL
55%
Loosely correlated
+1.91%
BEAM - ABCL
54%
Loosely correlated
-1.21%
PRME - ABCL
54%
Loosely correlated
-3.00%
AURA - ABCL
53%
Loosely correlated
-2.47%
More

PSTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, PSTX has been loosely correlated with QNRX. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if PSTX jumps, then QNRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PSTX
1D Price
Change %
PSTX100%
-0.11%
QNRX - PSTX
48%
Loosely correlated
-5.47%
ALEC - PSTX
46%
Loosely correlated
-4.55%
EDIT - PSTX
42%
Loosely correlated
+2.70%
PGEN - PSTX
42%
Loosely correlated
+2.46%
ABCL - PSTX
41%
Loosely correlated
-2.45%
More